Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: Role of NF-κB, p38 and JNK MAPK pathway

Toxicology and Applied Pharmacology

Volumn 240, Issue 1, 2009, Pages 73-87

  Ghosh, Jyotirmoy ^a   Das, Joydeep ^a   Manna, Prasenjit ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Apoptosis; Arsenic; Cardiac oxidative stress; Cardioprotection; NF B and MAPK; Taurine

Indexed keywords

ARSENIC; CALCIUM; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TAURINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART DISEASE; HEART MUSCLE CELL; HEART PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ARSENITES; CARDIOTONIC AGENTS; CELLS, CULTURED; ENZYME ACTIVATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE SIGNALING SYSTEM; MYOCARDIUM; MYOCYTES, CARDIAC; NF-KAPPA B; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RANDOM ALLOCATION; RATS; RATS, WISTAR; SODIUM COMPOUNDS; TAURINE;

EID: 69749106797     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.07.008     Document Type: Article

References (34)

1. Biasetti M., and Dawson R. Effects of sulfur containing amino acids on iron and nitric oxide stimulated catecholamine oxidation. Amino Acids 22 (2002) 351-368
2. Bode A., and Dong Z. Apoptosis induction by arsenic: mechanisms of actions and possible clinical applications for treating therapy-resistant cancers. J. Drug Resist. Updat. 3 (2000) 21-29
3. Bode A.M., and Dong Z. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit. Rev. Oncol./Hematol. 42 (2002) 5-24
4. Bueno O.F., and Molkentin J.D. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91 (2002) 776-778
5. Chang S.I., Jin B., Youn P., Park C., Park J.D., and Ryu D.Y. Arsenic-induced toxicity and the protective role of ascorbic acid in mouse testis. Toxicol. Appl. Pharmacol. 218 (2007) 196-203
6. Cowan K.J., and Storey K.B. Mitogen-activated protein kinases: new signalling pathways functioning in cellular responses to environmental stress. J. Exp. Biol. 206 (2003) 1107-1115
7. Das J., Ghosh J., Manna P., Sinha M., and Sil P.C. Arsenic-induced oxidative cerebral disorders: protection by taurine. Drug Chem. Toxicol. 32 (2009) 93-102
8. Das J., Ghosh J., Manna P., Sinha M., and Sil P.C. Taurine protects rat testes against NaAsO(2)-induced oxidative stress and apoptosis via mitochondrial dependent and independent pathways. Toxicol. Lett. 187 (2009) 201-210
9. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-421
10. Feuerstein G.Z., and Young P.R. Apoptosis in cardiac diseases: stress- and mitogen activated signaling pathways. Cardiovasc. Res. 45 (2000) 560-569
11. Forgione M.A., Cap A., Liao R., et al. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 106 (2002) 1154-1158
12. Ghosh J., Das J., Manna P., and Sil P.C. Cytoprotective effect of arjunolic acid in response to sodium fluoride mediated oxidative stress and cell death via necrotic pathway. Toxicol. In Vitro 22 (2008) 1918-1926
13. Grynkiewicz G., Poenie M., and Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
14. Hill M.F., and Singal P.K. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96 (1997) 2414-2420
15. Holloway C., Kotsanas G., and Wendt I. Acute effects of taurine on intracellular calcium in normal and diabetic cardiac myocytes. Pflugers Arch. 438 (1999) 384-391
16. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 72 (1992) 101-163
17. Korichneva I., Waka J., and Hammerling U. Regulation of the cardiac mitochondrial membrane potential by retinoids. J.P.E.T. 305 (2003) 426-433
18. Kornberg A. Lactic dehydrogenase of muscle. In: Colowick S.P., and Kaplan N.O. (Eds). Methods in Enzymology 1 (1955), Academic press, New York 441-443
19. Li J.M., Gall N.P., Grieve D.J., Chen M., and Shah A.M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40 (2002) 477-484
20. Li S., Li X., and Rozanski G.J. Regulation of glutathione in cardiac myocytes. J. Mol. Cell. Cardiol. 35 (2003) 1145-1152
21. Liu S.X., Athar M., Lippai I., Waldren C., and Hei T.K. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1643-1648
22. Manna P., Sinha M., Pal P., and Sil P.C. Arjunolic acid, a triterpenoid saponin, ameliorates arsenic-induced cyto-toxicity in hepatocytes. Chem. Biol. Interact. 170 (2007) 187-200
23. Manna P., Sinha M., and Sil P.C. Arsenic induced oxidative myocardial injury: protective role of arjunolic acid. Arch. Toxicol. 82 (2008) 137-149
24. Ratnaike R.N. Acute and chronic arsenic toxicity. Postgrad. Med. J. 79 (2003) 391-396
25. i dependent actions of taurine in spontaneously beating rabbit sino-atrial nodal cells. Eur. J. Pharmacol. 424 (2001) 19-25
26. Schulze-Osthoff K., Ferrari D., Riehemann K., and Wesselborg S. Regulation of NF-κB activation by MAP kinase cascades. Immunobiology 198 (1997) 35-49
27. Sil P., Kandaswamy V., and Sen S. Increased protein kinase C activity in myotrophin-induced myocyte growth. Circ. Res. 82 (1998) 1173-1188
28. Sinha M., Manna P., and Sil P.C. Taurine, a conditionally essential amino acid, ameliorates arsenic-induced cytotoxicity in murine hepatocytes. Toxicol. In Vitro 21 (2007) 1419-1428
29. Sole M.J., and Jeejeebhoy K.N. Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure. Curr. Opin. Clin. Nutr. Metab. Care 3 (2000) 417-424
30. Valen G., Hansson G.K., Dumitrescu A., and Vaage J. Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NF-κB and AP-1. Cardiovasc. Res. 47 (2000) 49-56
31. Yamanaka K., Hesegwa A., Sawamuna R., and Okada S. Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol. 108 (1991) 205-213
32. Yamauchi H., Aminaka Y., Yoshida K., Sun G., Pi J., and Waalkes M.P. Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol. Appl. Pharmacol. 198 (2004) 291-296
33. Yang S.H., Sharrocks A.D., and Whitmarsh A.J. Transcriptional regulation by the MAP kinase signaling cascades. Gene 320 (2003) 3-21
34. Yan-Jun X., Harjot K.S., Ming Z., Vijayan E., and Naranjan S.D. MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine. Cardiovasc. Res. 72 (2006) 163-174